1 / 58

Primary Cardiac Tumors

Primary Cardiac Tumors. Andrew Ferguson UIC January 3, 2008. Clinical Manifestations Systemic Findings Embolic Phenomena Cardiac Manifestations Diagnostic Evaluation Physical Examination Echocardiography Roentgenography Cardiac Catheterization MRI PET. Primary Tumors Benign

damisi
Télécharger la présentation

Primary Cardiac Tumors

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Primary Cardiac Tumors Andrew Ferguson UIC January 3, 2008

  2. Clinical Manifestations Systemic Findings Embolic Phenomena Cardiac Manifestations Diagnostic Evaluation Physical Examination Echocardiography Roentgenography Cardiac Catheterization MRI PET Primary Tumors Benign Benign or Malignant Malignant Treatment/Prognosis Observation Excision Chemo/Radiation Tx Recurrence Agenda

  3. Cardiac Tumor Occurrence • 0.002 to 0.3% incidence in autopsy series • Metastatic involvement of the heart is 20 times more common than primary lesions • Majority are benign (~75%)

  4. Clinical Presentations • Systemic • Symptoms • Biomarker abnormalities • Embolic Phenomena • Cardiac Manifestations • Mechanical Issues • Conduction Disturbances

  5. Systemic Findings • Non-specific signs/symptoms: • Fever, cachexia, malaise, arthralgias, Raynaud’s, rash, clubbing. • Constitutional symptoms • Laboratory findings: • Hypergammaglobulinemia, elevated ESR, thrombocytosis, thrombocytopenia, polycythemia, leukocytosis, and anemia.

  6. Etiology of Systemic Findings? • More often seen in myxomas • Synthesis and secretion of IL-6 • Inflammatory cytokine which induces the acute phase response • Prior to advanced imaging, not unusual for alternate diagnoses of collagen vascular disease, infection or non-cardiac malignancy to be made

  7. Embolic Phenomena • Tumor fragments or its adherent thrombus • Manifestation depends upon tumor location • PE. Can lead to PAH/cor pulmonale • Systemic infarct (MI, CVA, etc) • Vascular aneurysms and visceral hemorrhage • Multiple emboli can mimic systemic vasculitis or IE • Metastasis? • May help lead to diagnosis (I.e. skin biopsy)

  8. Cardiac Manifestations • Obstruction of circulation • Interference with valve function • Direct Invasion • Decreased myocardial contractility • Conduction disturbance (block and arrhythmias) • Tamponade

  9. Obstruction of Circulation • Symptoms correlate with location • i.e. left atrial tumors often mimic symptoms of MV disease by obstructing AV flow or causing MR (prolapse) • To differentiate from other cardiac diseases, tumor symptoms tend to have the following: • Sudden onset • Intermittent occurence • Positional dependence

  10. Diagnostic Evaluation • Purpose is to guide therapy: • Location • Size • Malignancy • Physical Exam • Echocardiography • Roentgenography • Cardiac Catheterization • CT • MRI

  11. Physical Exam • Again, dependent on location • LA tumors • Pulmonary congestion, S4, loud (widely split?) S1, diastolic murmur, MR murmur, tumor plop. • RA tumors • Right-sided congestion, diastolic murmur, TR, tumor plop. • RV tumors • Right-sided CHF, SEM, presystolic mm and diastolic rumble, S3, delayed P2. (differentiate from PS?) • LV tumors • SEM, positional changes of murmur and BP, other findings similar to AS, sub-aortic stenosis, HOCM, etc.

  12. In the old days… • Roetgenograms • Raised the suspicion, but rarely diagnostic • Cardiac Catheterization • Was relied upon to aid in diagnosis of cardiac tumor when suspicion was high. • Alternate imaging modalities have helped remove this potentially risky method. • Should still be used when: • Non-invasive eval did not fully define location/attachment • All cardiac chambers have not been visualized • Co-existing cardiac conditions are suspected and delineation with cath may change the surgical/treatment approach

  13. Examples

  14. Radionuclide Imaging • Inferior to echo/CT/MRI • Gated blood pool identifies atrial, ventricular and intramural tumors • Radionuclide ventriculography has relatively poor resolution compared to echo or contrast angio

  15. Echocardiography • 2-D echo has become initial study of choice • M-mode can still be helpful • Doppler useful for hemodynamic eval • TEE often indicated for full visualization • Tumor contour, cysts, calcification, stalk

  16. CT • Most useful when MRI is not available • Advantages: • Tissue discrimination: • Tumor extension, attachment • Reconstruction in any plane • Evaluation of involvement of pericardial and extracardiac structures

  17. MRI • Preferred over CT when available • In addition to that gained by CT, MRI: • T1- and T2-weighted sequences reflect the chemical microenvironment within a tumor

  18. Malignant vs. Benign Tumors • ~75% of cardiac tumors are benign. • Malignant tumors more likely to have: • distant metastases • local mediastinal invasion • evidence of rapid growth • hemorrhagic effusion • precordial pain • right-sided location • combined intramural and intracavitary location • extension into pulmonary veins

  19. TTE Example

  20. Benign Tumors

  21. Myxoma • Most common primary cardiac tumor • ~30-50% of all cardiac tumors in path series • Mean age 56 in sporadic cases (age 3-83) • 70% female • 86% occur in left atrium • 90% are solitary, intracavitary and located in atria.

  22. Cardiac Myxoma • Classic Triad: • Obstructive cardiac symptoms • Embolic phenomena • Constitutional symptoms • 20% Asymptomatic

  23. CT Left Atrial Myxoma

  24. Can you find it? Uncommon location - ~10%

  25. Atrial Myxoma Histo • Mucopolysaccharid matrix and vascular channels with ‘myxoma’ cells

  26. Treatment • Surgical resection is required: • High risk of embolization • Other CV complications, like sudden death • Operative mortality <5% • Generally curative • Cardiac transplant considered for multiple recurrent myxomas (occuring in 5%)

  27. Papillary Fibroelastoma • 2nd most common primary cardiac tumor of adults • Some synonyms: • Giant Lambl excrescence • Papilloma of valves • Myxofibroma • Myxoma of valves • Hyaline fibroma • Fibroma of valves

  28. Clinical Features • >80% are found on heart valves: • Mainly left-sided valves • Account for ~75% of all valve tumors • Men and women affect ~equally • Mean age 60 years at diagnosis • Multiple tumors in 9% of patients

  29. Clinical Features cont. • Symptoms usually due to embolization of either tumor or thrombus. • Most commonly CVA/TIA • Also angina, MI, SCD, CHF, syncope, or systemic/pulmonic embolic events • Up to 30% are asymptomatic and diagnosed incidentally at time of an echo, cardiac surgery or autopsy

  30. Histopathology • Benign endocardial papillomas • Characteristic frondlike appearance • Mean tumor size 9mm (range 2-70mm) • Core of loose connective tissue: • Rich in glycosaminoglycans, collagen and elastic fibers • Fine meshwork of smooth muscle cells • This core is surrounded by endothelium

  31. Papillary fibroelastoma

  32. Treatment • Surprisingly no evidence • Surgery definitively indicated in patients: • Who have had embolic events • With highly mobile or large (>1cm) tumors • Some suggest careful observation is acceptable for asymptomatic patients • Recurrence after surgery has not been reported

  33. Lipoma • Rare (~3% of primary cardiac tumors) • Predominantly adults • Occur in the subendocardium, myocardium and subepicardium • Symptoms related to local tissue encroachment (arrhythmia, heart block, and sudden death)

  34. Histopathology • Circumscribed, spherical or elliptical mass • Composed of mature adipocytes • Differ from lipomatous hypertrophy of IAS: • Usually encapsulated • No brown fat cells • No myocytes found

  35. Treatment • Require resection due to the symptoms they cause and their progressive growth.

  36. Lipomatous septal hypertrophy • Not a true tumor • Exaggerated growth of normal fat in IAS • Up to 2cm in thickness • Seen in elderly and obese people • Only consider surger if symptomatic: • Atrial arrhythmias • Heart block

  37. Rhabdomyomas • Primarily pediatric • Usually age <1 year • Highly associated with tuberous sclerosis • Found on ventricular walls or AV valves • Infrequent symptoms of obstruction and arrhythmias • Usually regress spontaneously

  38. Fibromas • 2nd most common pediatric tumor • Rarely also occurs in adults • Usually arise in ventricular muscle • Heart failure due to: • Obstruction • Interference with valvular function • Myocardial dysfunction

  39. Treatment • Symptomatic tumors are resected • Very large tumors may require resection

  40. Teratoma • Obviously a pediatric issue • Arise within pericardium • Benign in nature but cause drastic complications via tamponade • High risk of death in-utero or after birth • Requires fetal excision or C-section and immediate operation

  41. Angiomas • Extremely rare • Benign proliferations of endothelial cells • Generally found incidentally, but can cause symptoms commensurate with their location • Surgical resection if symptomatic

  42. Paraganglioma • Extremely rare • Arise from chromaffin cells, mainly in atria • Majority produce catecholamines • Positive biomarkers similar to pheo • 20% of patients also have extracardiac tumor • Surgical excision is definitive treatment

  43. Mesothelioma • Can be both benign and malignant • More commonly arise in the pericardium, also rarely arise in the AV node • Pericardial mesothelioma: • Likely malignant • May produce tamponade • Resection is treatment of choice, but remains poor prognosis if malignant • AV node mesothelioma: • Benign • May produce heart block and sudden death

  44. Malignant Tumors

  45. Sarcomas • Constitute most of all malignant tumors • Overall, 2nd most common cardiac tumor • Virtually all cell types have been reported • Clinical presentation depends on location, rather than its histopathology.

  46. Angiosarcoma • Composed of malignant cells that form vascular channels • Predominantly in the right atrium

  47. Rhabdomyosarcoma • Constitute 20% of all cardiac sarcomas • Mostly adults, also described in children • Multiple sites are common, no site predilection

More Related